2024/0016,850 | CELL-NANOPARTICLE DRUG DELIVERY SYSTEM AND USE OF THE SAME FOR INHIBITING GROWTH OF TUMOR CELLS AND DIAGNOSING TUMOR CELLS | Jul 17, 23 | Jan 18, 24 | Not available |
2024/0018,476 | DEVICES AND METHODS FOR ISOLATING TUMOR INFILTRATING LYMPHOCYTES AND USES THEREOF | May 09, 23 | Jan 18, 24 | INSTIL BIO (UK) LIMITED |
2024/0018,237 | ROR1 BINDING PROTEIN AND USE THEREOF | Feb 28, 22 | Jan 18, 24 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.; KLUS PHARMA INC.; |
2024/0018,218 | ANTIVIRAL COMPOSITION AGAINST INFLUENZA A VIRUS | Sep 08, 21 | Jan 18, 24 | Not available |
2024/0016,780 | METHODS OF INCREASING MAGNESIUM BIOAVAILABILITY AND ABSORPTION | Sep 27, 23 | Jan 18, 24 | Not available |
2024/0016,902 | Application of RDR protein in tumor therapy | Aug 20, 21 | Jan 18, 24 | Not available |
2024/0016,948 | SINGLE PROTEIN-ENCAPSULATED PHARMACEUTICS FOR ENHANCING THERAPEUTIC EFFECTS | Mar 30, 23 | Jan 18, 24 | Sunstate Biosciences, LLC |
2024/0018,227 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH TGF-BETA ACTIVITY | Oct 27, 21 | Jan 18, 24 | Not available |
2024/0016,877 | ANTIBIOTIC COMPOSITION AND METHOD OF MANUFACTURING THE SAME | Sep 20, 22 | Jan 18, 24 | Not available |
2024/0016,838 | ENGINEERED NK CELLS | Oct 26, 21 | Jan 18, 24 | Not available |
2024/0018,192 | LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF | Aug 18, 23 | Jan 18, 24 | Not available |
2024/0016,801 | FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA | Jun 26, 23 | Jan 18, 24 | Not available |
2024/0018,207 | INTERFERON TAU FC-FUSION PROTEINS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS | Sep 22, 21 | Jan 18, 24 | Not available |
2024/0016,776 | METHOD FOR REDUCING CUTANEOUS SKIN SCARRING BY PRE-EMPTIVE PRIMING AND COMPOUNDS AND COMPOSITIONS FOR ITS IMPLEMENTATION | Aug 25, 21 | Jan 18, 24 | Not available |
2024/0016,818 | NOVEL USE OF GLUCOCORTICOIDS FOR THE TREATMENT OF EPITHELIAL MICROBIAL INFECTIONS OF A FLUID CONTAINING ORGAN WITH A NATURAL EXTERIOR ORIFICE IN MAMMALS | Sep 27, 23 | Jan 18, 24 | Virbac SA |
2024/0018,517 | MODULATING HEMATAOPOIESIS AND MYLEOID CELL PRODUCTION | Nov 12, 21 | Jan 18, 24 | Not available |
2024/0016,769 | Method for preparing compound or biological drug enhancing CNPase activity for treating heart diseases | Nov 14, 21 | Jan 18, 24 | Not available |
2024/0018,245 | DOSING FOR TREATMENT WITH ANTI-FCRH5/ANTI-CD3 BISPECIFIC ANTIBODIES | Apr 04, 23 | Jan 18, 24 | Not available |
2024/0018,254 | ANTI-CD73 ANTIBODY AND USE THEREOF | Oct 22, 21 | Jan 18, 24 | Not available |
2024/0016,793 | QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE | Aug 02, 23 | Jan 18, 24 | Not available |